ASTELLAS PHARMA A/S: Financial statements 2021
CVR: 10888638
Source: annual report 2021, Danish Business Authority
01/04/2020 – 31/03/2021
ASTELLAS PHARMA A/S (CVR 10888638) has filed annual accounts for 2021. In 2021, the company reported revenue of EUR 160,457,000 and a net result of EUR 5,865,000 compared with EUR 2,036,000 the year before. That is a decrease of 14.2% compared with the year before. The profit margin was 3.7%. Equity in the 2021 report amounted to EUR 59,437,000. The solvency ratio was 40.9%. The company had 115 employees in the financial year.
- Revenue
- EUR 160,457,000
- Gross Profit
- EUR 24,102,000
- Profit/Loss
- EUR 5,865,000
- Equity
- EUR 59,437,000
- Total Assets
- EUR 145,455,000
- Employees
- 115
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 160.5M EUR | 24.1M EUR | 5.9M EUR | 59.4M EUR | 115 |
| 2020 | 187M EUR | 23.8M EUR | 2M EUR | 53.6M EUR | 114 |
| 2019 | 182.6M EUR | 25M EUR | 4.7M EUR | 56.2M EUR | 116 |
| 2018 | 157.8M EUR | 20.5M EUR | 2.6M EUR | 54.1M EUR | 115 |
| 2017 | 144.9M EUR | 17.9M EUR | 12.2M EUR | 51.5M EUR | 117 |
Official annual report
Find more companies like ASTELLAS PHARMA A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of December 14, 2021, Rowena Borenstein has joined the board of directors of ASTELLAS PHARMA A/S.
As of December 14, 2021, Niels Walther-Rasmussen has left the board of directors of ASTELLAS PHARMA A/S.
As of July 1, 2021, Malene Abildstrøm has joined the board of directors of ASTELLAS PHARMA A/S.
As of July 1, 2021, Karl Håkan Lennart Widen has joined the board of directors of ASTELLAS PHARMA A/S.
As of July 1, 2021, Pia Terésa Lindkvist has left the board of directors of ASTELLAS PHARMA A/S.
As of June 7, 2021, Karl Håkan Lennart Widen is registered as adm. dir. of ASTELLAS PHARMA A/S.
As of June 7, 2021, Pia Terésa Lindkvist has stepped down as adm. dir. of ASTELLAS PHARMA A/S.
About ASTELLAS PHARMA A/S
ASTELLAS PHARMA A/S is a Danish company of the type Aktieselskab based in København S, founded in 1987. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named YAMANOUCHI PHARMA A/S and BROCADES PHARMA A/S. The management consists of Mark Andree Dekker. The board consists of Damla Ebru Atilgan (chair), Anne Nymand, Giuseppe Maduri and Mark Andree Dekker. The company is owned by Astellas Pharma Europe LTD.. The company has 67 employees (2026). In 2026, the company reported revenue of EUR 197,863,000 and a net result of EUR 5,229,000 compared with EUR 5,705,000 the year before. Equity in the 2026 report amounted to EUR 20,071,000.